ROZUSAF F 20MG TABLET

Product Description

ROZUSAF F 20MG TABLET
Composition: Rosuvastatin 20mg + Fenofibrate 160mg

Product Description:
ROZUSAF F 20MG TABLET is a powerful combination therapy designed to effectively manage dyslipidemia by targeting elevated cholesterol and triglyceride levels. Combining Rosuvastatin, a potent HMG-CoA reductase inhibitor, with Fenofibrate, a fibrate derivative, this formulation offers a comprehensive approach to improving lipid profiles, reducing LDL cholesterol, increasing HDL cholesterol, and lowering triglycerides.

Key Benefits:

• Dual-action lipid management for enhanced cardiovascular protection

• Reduces LDL (bad cholesterol) and triglycerides efficiently

• Increases HDL (good cholesterol) to support heart health

• Supports prevention of atherosclerosis and related complications

• Suitable for patients with mixed dyslipidemia or those unresponsive to monotherapy

Usage:
ROZUSAF F 20MG TABLET is indicated for adult patients requiring combined lipid-lowering therapy. It is recommended to be used under medical supervision, alongside lifestyle modification including diet and exercise, for optimal results.

Why Choose ROZUSAF F 20MG:

• High-quality pharmaceutical grade formulation

• Manufactured under strict GMP guidelines ensuring safety and efficacy

• Available in bulk packaging ideal for distributors, retailers, and healthcare institutions

• Competitive pricing tailored for B2B procurement needs

Target Audience:
Pharmaceutical distributors, medical retailers, hospitals, clinics, and bulk buyers looking to expand their cardiovascular and lipid management product portfolio with a trusted combination therapy.